|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.94 USD | +3.39% |
|
-3.26% | +8.29% |
| Jan. 13 | TD Cowen Adjusts Price Target on Incyte to $128 From $101, Maintains Buy Rating | MT |
| Jan. 12 | Incyte Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 08:15 AM |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- INCY Stock
- Consensus Incyte Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
